Hamid Trimech | Business Development
ARCALIS, Inc.

Hamid Trimech, Business Development, ARCALIS, Inc.

Hamid Trimech is a talented process engineer passionate about vaccine manufacturing.  For over 8 years in the vaccine industry, Hamid has led numerous projects involving the design, construction, and qualification of drug substance manufacturing facilities. Throughout his activities, he has supported technology transfers, process validations, and commercial manufacturing of a wide range of vaccine technologies, including whole cell, acellular pertussis, egg-based flu, rabies, diphtheria, tetanus, pneumococcal conjugate, recombinant protein COVID-19, and mRNA-based COVID-19 vaccines.  Since joining ARCALIS in September 2022, Hamid has taken on the role of Project Leader. In this capacity, he has successfully led the construction of ARCALIS' drug substance facility and the technology transfer of sa-mRNA and LNP manufacturing processes.  Since 2025, Hamid has taken on business development in addition to his existing responsibilities. He is now leading the team as the Head of the Business Development Division.  

Appearances:



Day 1 (20th October) @ 16:00

Beyond COVID-19 and strategies for better mRNA vaccines

Session led by: ARCALIS, Inc.
last published: 16/Apr/26 16:05 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2026

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com


Stan Dooley

Stan.Dooley@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.